Author:
Pape Andreas,Habler Oliver
Publisher
Springer Berlin Heidelberg
Reference124 articles.
1. Agrawal YP, Freedman M, Szczepiorkowski ZM. Long-term transfusion of polymerized bovine hemoglobin in a Jehovah’s Witness following chemotherapy for myeloid leukemia: a case report. Transfusion. 2005;45:1735–8.
2. Alayash AI. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants? Nat Biotechnol. 1999;17:545–9.
3. Amberson WR, Jennings JJ, Rhode CM. Clinical experience with hemoglobin-saline-solutions. J Appl Physiol. 1949;1: 469–89.
4. Barnikol WK, Potzschke H. Haemoglobin hyperpolymers, a new type of artificial oxygen carrier - the concept and current state of development. Anaesthesiol Intensivmed Notfallmed Schmerzther. 2005;40:46–58.
5. Bjorkholm M, Fagrell B, Przybelski R, Winslow N, Young M, Winslow RM. A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol. Haematologica. 2005;90:505–15.